Profile
Joe Flanagan is currently Chief Business Officer at AccuStem Sciences, Inc. since 2022.
Former positions include Principal at Amgen, Inc. and Johnson & Johnson; Manager-Regional Accounts at Novartis Oncology, Inc.; Vice President-Market Development at Biodesix, Inc. and Agendia, Inc.; Vice President-Sales at Helomics Corp.
and Axe Compute, Inc.; Area Vice President-Sales at Biodesix, Inc. from 2015 to 2018; Vice President-Market Development at Agendia NV from 2018 to 2019; and Vice President-Sales at CirculoGene Theranostics, Inc. from 2018 to 2019.
Education includes undergraduate studies at Florida State University.
Joe Flanagan active positions
| Companies | Position | Start |
|---|---|---|
| ACCM SCIE | Corporate Officer/Principal | 2022-03-03 |
Former positions of Joe Flanagan
| Companies | Position | End |
|---|---|---|
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology Operates as molecular diagnostics company, develops test for cfDNA liquid biopsies | Sales & Marketing | 2019-06-30 |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Sales & Marketing | 2019-04-30 |
| BIODESIX, INC. | Sales & Marketing | 2018-06-30 |
| PRECISION THERAPEUTICS INC | Sales & Marketing | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Corporate Officer/Principal | - |
Training of Joe Flanagan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Biodesix, Inc.
Biodesix, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic research and clinical trial testing services & engages in discovery, development and commercialization of therapeutics | Health Services |
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Health Services |
Helomics Corp.
Helomics Corp. Miscellaneous Commercial ServicesCommercial Services Provides cancer care development and treatment consulting services | Commercial Services |
Predictive Oncology, Inc.
Predictive Oncology, Inc. Medical SpecialtiesHealth Technology Operates as a development stage company manufacturing an environmentally conscientious system for the collection and disposal of infectious fluids | Health Technology |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Health Technology |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology Operates as molecular diagnostics company, develops test for cfDNA liquid biopsies | Health Technology |
AccuStem Sciences, Inc.
AccuStem Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomics-based personalized medicines for breast cancer patients | Health Technology |
- Stock Market
- Insiders
- Joe Flanagan
















